Averto Medical, a clinical-stage medical device company pioneering minimally invasive gastrointestinal care, is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted ...
Averto Medical, a clinical-stage medical device company pioneering minimally invasive gastrointestinal care, is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted ...
The FDA has approved the BLA for Ospomyv™ and Xbryk™, biosimilars to Prolia (denosumab) and Xgeva (denosumab), respectively.
The following article, which first saw the light of day in May 2014, is an example of why there can more to a story than ...
The following article, which first appeared in The Post-Journal in May 2014, is an example of why there can more to a story ...
A family is preparing for three fundraising challenges in memory of their husband and dad who received treatment at an Oxford hospital.
"Woman," "elderly," and "disabled" were among a list of banned words reportedly circulating within the FDA, which the White ...
Shannin Desroches fought for a diagnosis after being dismissed. Now she tells PEOPLE that she's been given a 5% chance of ...
Celltrion expands its reach in Europe, securing marketing authorization from the European Commission (EC) for its denosumab biosimilar candidate (Stoboclo and Osenvelt) and its aflibercept biosimilar ...
The FDA approved the denosumab biosimilar Ospomyv, interchangeable with Prolia, for preventing osteoporosis-related fracture ...
Dr. Greg Vigna Debridement for decubitus ulcers must align with treatment goals, with early reconstructive surgery recommended to avoid ris ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback